LT3481811T - Kariprazino pramoninis gavimo būdas - Google Patents
Kariprazino pramoninis gavimo būdasInfo
- Publication number
- LT3481811T LT3481811T LTEPPCT/IB2017/054094T LTIB2017054094T LT3481811T LT 3481811 T LT3481811 T LT 3481811T LT IB2017054094 T LTIB2017054094 T LT IB2017054094T LT 3481811 T LT3481811 T LT 3481811T
- Authority
- LT
- Lithuania
- Prior art keywords
- cariprazine
- preparation
- industrial process
- industrial
- Prior art date
Links
- KPWSJANDNDDRMB-QAQDUYKDSA-N cariprazine Chemical compound C1C[C@@H](NC(=O)N(C)C)CC[C@@H]1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 KPWSJANDNDDRMB-QAQDUYKDSA-N 0.000 title 1
- 229960005123 cariprazine Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1600420 | 2016-07-08 | ||
| HU1700197A HU231173B1 (hu) | 2016-07-08 | 2017-05-09 | Ipari eljárás cariprazine előállítására |
| PCT/IB2017/054094 WO2018007986A1 (en) | 2016-07-08 | 2017-07-07 | Industrial process for the preparation of cariprazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3481811T true LT3481811T (lt) | 2022-08-25 |
Family
ID=89992438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/IB2017/054094T LT3481811T (lt) | 2016-07-08 | 2017-07-07 | Kariprazino pramoninis gavimo būdas |
Country Status (22)
| Country | Link |
|---|---|
| EP (2) | EP4043446A3 (lt) |
| JP (1) | JP7065824B2 (lt) |
| CN (1) | CN109476617B (lt) |
| AU (1) | AU2017292177B2 (lt) |
| BR (1) | BR112018077305A2 (lt) |
| CA (1) | CA3030102A1 (lt) |
| DK (1) | DK3481811T3 (lt) |
| EA (1) | EA036312B1 (lt) |
| ES (1) | ES2924995T3 (lt) |
| GE (1) | GEP20217217B (lt) |
| HR (1) | HRP20221037T1 (lt) |
| HU (2) | HU231173B1 (lt) |
| IL (1) | IL264074B (lt) |
| LT (1) | LT3481811T (lt) |
| MX (2) | MX2019000330A (lt) |
| PL (1) | PL3481811T3 (lt) |
| PT (1) | PT3481811T (lt) |
| RS (1) | RS63480B1 (lt) |
| SG (1) | SG11201811291QA (lt) |
| SI (1) | SI3481811T1 (lt) |
| UA (1) | UA123797C2 (lt) |
| WO (1) | WO2018007986A1 (lt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110240548A (zh) * | 2018-03-09 | 2019-09-17 | 上虞京新药业有限公司 | 一种卡利拉嗪中间体的制备方法 |
| CN110317182B (zh) * | 2018-03-29 | 2021-10-15 | 上虞京新药业有限公司 | 一种卡利拉嗪的制备方法 |
| CN108586389B (zh) * | 2018-06-29 | 2020-06-12 | 成都福柯斯医药技术有限公司 | 一种合成卡利拉嗪的方法 |
| CN111712486B (zh) * | 2018-09-21 | 2024-09-13 | 上海诚妙医药科技有限公司 | 卡利拉嗪盐酸盐的晶型及其制备方法及其用途 |
| CN114539185A (zh) * | 2020-11-24 | 2022-05-27 | 上海博志研新药物技术有限公司 | 一种卡利拉嗪及其中间体的制备方法 |
| HUP2100108A1 (hu) | 2021-03-12 | 2022-09-28 | Richter Gedeon Nyrt | Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására |
| CN115806510B (zh) * | 2023-02-03 | 2023-04-21 | 成都福柯斯医药技术有限公司 | 3-反式-4-(2-羟乙基)环己基-1,1-二甲基脲的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010009912A1 (en) | 1995-02-10 | 2001-07-26 | Christos Tsaklakidis | New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds |
| HU227543B1 (en) * | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| UY29161A1 (es) | 2004-10-15 | 2006-04-28 | Bayer Pharmaceuticals Corp | Nuevos heterociclos |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HU229858B1 (en) * | 2008-12-17 | 2014-10-28 | Richter Gedeon Nyrt | Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl |
| US8912197B2 (en) * | 2012-08-20 | 2014-12-16 | Forest Laboratories Holdings Ltd. | Crystalline form of carbamoyl-cyclohexane derivatives |
| HU231227B1 (hu) * | 2012-11-29 | 2022-03-28 | Richter Gedeon Nyrt. | Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére |
| ITMI20131693A1 (it) | 2013-10-14 | 2015-04-15 | Chemo Res S L | Derivati della 1,4-cicloesilammina e loro preparazione |
| CN105218484B (zh) * | 2015-09-14 | 2018-02-23 | 安徽省逸欣铭医药科技有限公司 | 酒石酸卡利拉嗪及其制备方法和医药用途 |
| CN105330616B (zh) | 2015-12-09 | 2017-09-26 | 苏州明锐医药科技有限公司 | 卡利拉嗪的制备方法 |
-
2017
- 2017-05-09 HU HU1700197A patent/HU231173B1/hu unknown
- 2017-07-07 EP EP22165881.8A patent/EP4043446A3/en active Pending
- 2017-07-07 WO PCT/IB2017/054094 patent/WO2018007986A1/en unknown
- 2017-07-07 BR BR112018077305-0A patent/BR112018077305A2/pt unknown
- 2017-07-07 EA EA201990097A patent/EA036312B1/ru unknown
- 2017-07-07 MX MX2019000330A patent/MX2019000330A/es unknown
- 2017-07-07 UA UAA201901278A patent/UA123797C2/uk unknown
- 2017-07-07 ES ES17739701T patent/ES2924995T3/es active Active
- 2017-07-07 HU HUE17739701A patent/HUE059285T2/hu unknown
- 2017-07-07 MX MX2021012390A patent/MX2021012390A/es unknown
- 2017-07-07 CN CN201780042429.9A patent/CN109476617B/zh active Active
- 2017-07-07 SI SI201731213T patent/SI3481811T1/sl unknown
- 2017-07-07 RS RS20220747A patent/RS63480B1/sr unknown
- 2017-07-07 DK DK17739701.5T patent/DK3481811T3/da active
- 2017-07-07 AU AU2017292177A patent/AU2017292177B2/en active Active
- 2017-07-07 EP EP17739701.5A patent/EP3481811B1/en active Active
- 2017-07-07 LT LTEPPCT/IB2017/054094T patent/LT3481811T/lt unknown
- 2017-07-07 JP JP2019500444A patent/JP7065824B2/ja active Active
- 2017-07-07 GE GEAP201714994A patent/GEP20217217B/en unknown
- 2017-07-07 PL PL17739701.5T patent/PL3481811T3/pl unknown
- 2017-07-07 CA CA3030102A patent/CA3030102A1/en not_active Abandoned
- 2017-07-07 HR HRP20221037TT patent/HRP20221037T1/hr unknown
- 2017-07-07 PT PT177397015T patent/PT3481811T/pt unknown
- 2017-07-07 SG SG11201811291QA patent/SG11201811291QA/en unknown
-
2019
- 2019-01-03 IL IL264074A patent/IL264074B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4043446A2 (en) | 2022-08-17 |
| PL3481811T3 (pl) | 2022-09-12 |
| MX2021012390A (es) | 2022-07-18 |
| EP3481811A1 (en) | 2019-05-15 |
| HUE059285T2 (hu) | 2022-11-28 |
| CN109476617A (zh) | 2019-03-15 |
| EP4043446A3 (en) | 2023-01-18 |
| PT3481811T (pt) | 2022-08-23 |
| DK3481811T3 (da) | 2022-09-05 |
| AU2017292177B2 (en) | 2021-07-29 |
| EA036312B1 (ru) | 2020-10-26 |
| CN109476617B (zh) | 2023-04-04 |
| IL264074A (en) | 2019-01-31 |
| AU2017292177A1 (en) | 2019-02-07 |
| HU231173B1 (hu) | 2021-06-28 |
| EA201990097A1 (ru) | 2019-06-28 |
| CA3030102A1 (en) | 2018-01-11 |
| JP7065824B2 (ja) | 2022-05-12 |
| GEP20217217B (en) | 2021-02-10 |
| EP3481811B1 (en) | 2022-05-25 |
| MX2019000330A (es) | 2019-05-20 |
| SI3481811T1 (sl) | 2022-10-28 |
| WO2018007986A1 (en) | 2018-01-11 |
| SG11201811291QA (en) | 2019-01-30 |
| HUP1700197A2 (en) | 2018-09-28 |
| HRP20221037T1 (hr) | 2022-11-11 |
| IL264074B (en) | 2021-10-31 |
| JP2019527210A (ja) | 2019-09-26 |
| ES2924995T3 (es) | 2022-10-13 |
| RS63480B1 (sr) | 2022-08-31 |
| UA123797C2 (uk) | 2021-06-02 |
| BR112018077305A2 (pt) | 2019-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3433285T1 (sl) | Izboljšan postopek za pripravo sugamadeksa | |
| ZA201706795B (en) | Process for the preparation of dicycloplatin | |
| IL264074B (en) | Industrial process for the preparation of caprazine | |
| ZA201902125B (en) | Process for the production of 2-alkylalkanol | |
| IL248267B (en) | A process for preparing converted cycloserines | |
| IL266589B1 (en) | A process for the preparation of omclidinium bromide | |
| ZA201804783B (en) | Process for the preparation of 4-alkoxy-3-acetoxypicolinic acids | |
| IL268835B (en) | A process for the preparation of 2-cyanoimidazole compounds | |
| IL275480A (en) | A process for the preparation of pyrimidinyl-4-aminopyrazole compounds | |
| ZA201804877B (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
| ZA201608307B (en) | Process for the purification of l-alpha-glycerophosphorylcholine | |
| IL247443B (en) | Process for the preparation of 5-fluorotryptophol | |
| IL262889B (en) | Process for the manufacture of 6-alkynyl-pyridine derivatives | |
| HUP1600671A2 (en) | Industrial process for the preparation of nomegestrol acetate | |
| GB201505667D0 (en) | Process for the preparation of butadiene | |
| HK1258181A1 (zh) | 製備螯合劑的方法 | |
| GB2552697B (en) | Process for the preparation of boscalid | |
| HUE051643T2 (hu) | Tömbpolimerizációs folyamat polidiének elõállítására | |
| HUP1600058A2 (en) | Process for the preparation of pomalidomide | |
| HUP1400434A2 (hu) | Új ipari eljárás egy szulfonamid származék elõállítására |